Skip to main content

Prime Medicine, Inc 10-Q for FY2024 Q3

Prime Medicine, Inc. (PRME)

10-Q 2024-11-12 For: 2024-09-30
View Original
Added on April 07, 2026

About this 10-Q

Prime Medicine, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$209K
compared with $0 a year earlier
Net loss
$52.52M
compared with a net loss of $50.71M a year earlier
Diluted EPS
-$0.44
compared with -$0.55 a year earlier